3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
18
Neoplasms
14
Ovarian Neoplasms
7
Lung Neoplasms
7
Leukemia, Myeloid, Acute
7
Lymphoma
6
Neoplasm Metastasis
5
Multiple Myeloma
5
Hematologic Neoplasms
5
Prostatic Neoplasms
4
Leukemia
4
Glioblastoma
4
Fatigue
4
Colorectal Neoplasms
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Sarcoma
3
Pancreatic Neoplasms
3
Myelodysplastic Syndromes
3
Depression
3
Anxiety Disorders
3
Vaginal Neoplasms
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Peritoneal Neoplasms
2
Pain
2
Motor Activity
2
Melanoma
2
Interventions
Exercise
8
salicylhydroxamic acid
2
High-Intensity Interval Training
2
Electrocardiography
2
Echocardiography
2
sacubitril and valsartan sodium hydrate drug combination
1
mitoquinone
1
epicatechin gallate
1
candesartan
1
Therapeutics
1
Surveys and Questionnaires
1
Secondary Prevention
1
Restraint, Physical
1
Rehabilitation
1
Proton Therapy
1
Proteins
1
Palliative Care
1
Methods
1
Medical History Taking
1
Magnetic Resonance Spectroscopy
1
Laser-Doppler Flowmetry
1
Ivabradine
1
Heart Rate
1
Heart Function Tests
1
Exercise Test
1
Echocardiography, Stress
1
Diagnostic Imaging
1
Cardiac Rehabilitation
1
Blood Pressure
1
Blood Cell Count
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Cardiotoxicity
×
Palliative Care
×
Clear all
NCT04598646
2025-12-03
HIMALAYAS-P
University Health Network, Toronto
Phase NA
Completed
30 enrolled